Professional Publications

Pokorná, D.; Macková, J.; Dušková, M.; Rittich, Š.; Ludvíková, V.; Šmahel, M.:

Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect.

[year of publication 2006, impact factor 3.699]

Votavova, H.; Dostalova Merkerova, M.; Fejglova, K.; Vasikova, A.; Krejcik, Z.; Pastorkova, A.; Tabashidze, N.; Topinka, J.; Veleminsky, M. Jr.; Sram, R.J.; Brdicka, R.

Transcriptome alterations in maternal and fetal cells induced by tobacco smoke

[year of publication 2011, impact factor 3.693 ]

Roubalová, K.; Němečková, Š.; Kryštofová, J.; Hainz, P.; Pumannová, M.; Hamšíková, E.

Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients

[year of publication 2020, impact factor 3.685 ]

Petrak, J.; Myslivcova, D.; Man, P.; Cmejla, R.; Cmejlova, J.; Vyoral, D.

Proteomic analysis of iron overload in human hepatoma cells

[year of publication 2007, impact factor 3.681]

Krijt, M.; Jirkovska, A.; Kabickova, T.; Melenovsky, V.; Petrak, J.; Vyoral, D.

Detection and quantitation of iron in ferritin, transferrin and labile iron pool (LIP) in cardiomyocytes using 55Fe and storage phosphorimaging

[year of publication 2018, impact factor 3.681 ]

Nemeckova, S.; Alexova-Zurkova, K.; Hainz, P.; Krystofova, J.; Mackova, J.; Roubalova, K.; Stastna-Markova, M.; Vrana, M.; Vydra, J.

Non-mutated nucleophosmin 1 is recognized by the CD8+ T lymphocytes of an AML patient after the transplantation of hematopoietic stem cells from an HLA-haploidentical donor

[year of publication 2022, impact factor 3.677 ]

Klanova, M.; Soukup, T.; Jaksa, R.; Molinsky, J.; Lateckova, L.; Maswabi, B.C.L.; Prukova, D.; Brezinova, J.; Michalova, K.; Vockova, P.; Hernandez-Ilizaliturri, F.; Kulvait, V.; Zivny, J.; Vokurka, M.; Necas, E.; Trneny, M.; Klener, P.

Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research

[year of publication 2014, impact factor 3.676 ]

Brodská, B.; Šašinková, M.; Kuželová, K.

Nucleophosmin in leukemia: consequences of anchor loss

[year of publication 2019, impact factor 3.673 ]

Baumeister, J.; Maié, T.; Chatain, N.; Gan, L.; Weinbergerova, B.; de Toledo, M.A.S.; Eschweiler, J.; Maurer, A.; Kubesova, B.; Racil, Z.; et al.

Early and late stage MPN patients show distinct gene expression profiles in CD34(+) cells

[year of publication 2021, impact factor 3.673 ]

Pimková, K.; Bocková, M.; Hegnerová, K.; Suttnar, J.; Čermák, J.; Homola, J.; Dyr, J.E.

Surface plasmon resonance biosensor for the detection of VEGFR-1-a protein marker of myelodysplastic syndromes

[year of publication 2011, impact factor 3.659 ]

Mobius, S.; Schenk, T.; Himsel, D.; Maier, J.; Franke, G.-N.; Saussele, S.; Pott, C.; Andrikovics, H.; Meggyesi, N.; Machova-Polakova, K.; Zizkova, H.; et al.

Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)

[year of publication 2019, impact factor 3.656 ]

Andersen, N.S.; Bornhäuser, M.; Gramatzki, M.; Dreger, P.; Vitek, A.; et al.

Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning

[year of publication 2019, impact factor 3.656 ]

Hengeveld, M.; Suciu, S.; Chelgoum, Y.; Marie, J.-P.; Muus, P.; Lefrere, F.; Mandelli, F.; Pane, F.; Amadori, S.; Fioritoni, G.; Labar, B.; Baron, F.; Cermak, J.; Bourhis, J.-H.; Storti, G.; Fazi, P.; Hagemeijer, A.; Vignetti, M.; Willemze, R.; De Witte, T.

High numbers of mobilized CD34+cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT

[year of publication 2015, impact factor 3.636 ]

Handrkova, H.; Petrak, J.; Halada, P.; Pospisilova, D.; Cmejla, R.

Tyrosine 87 is vital for the activity of human protein arginine methyltransferase 3 (PRMT3)

[year of publication 2010, impact factor 3.635]

Pokorná, D.; Poláková, I.; Kindlová, M.; Dušková, M.; Ludvíková, V.; Gabriel, P.; Kutinová, L.; Müller, M.; Šmahel, M.

Vaccination with human papillomavirus type 16-derived peptides using a tattoo device

[year of publication 2009, impact factor 3.616]

Kasim, N.R.; Kuželová, K.; Holoubek, A.; Model, M.A.

Live fluorescence and transmission-through-dye microscopic study of actinomycin D-induced apoptosis and apoptotic volume decrease

[year of publication 2013, impact factor 3.614 ]

Štulc, T.; Vrablík, M.; Kasalová, Z.; Češka, R.; Marinov, I.

Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia

[year of publication 2006, impact factor 3.603]

Midgley, C.A.; Fisher, C.; Bartek, J.; Vojtesek, B.; Lane, D.P.; Barnes, D.M.

Analysis of p53 expression in human tumours : an antibody raised against human p53 expressed in Escherichia coli

[year of publication 2006, impact factor 3.593]

Kuželová, K.; Grebeňová, D.; Marinov, I.; Hrkal, Z.

Fast apoptosis and erythroid differentiation induced by Imatinib mesylate in JURL-MK1 cells.

[year of publication 2006, impact factor 3.591]

Racil, Z.; Razga, F.; Buresova, L.; Jurcek, T.; Dvorakova, D.; Zackova, D.; Timilsina, S.; Cetkovsky, P.; Mayer, J.

The assessment of human organic cation transporter 1 (hOCT1) mRNA expression in patients with chronic myelogenous leukemia is affected by the proportion of different cells types in the analyzed cell population

[year of publication 2010, impact factor 3.576]